IRIS, a randomised, double-blind, placebo-controlled trial of interleukin-6 receptor inhibition undergoing endovascular treatment in acute anterior circulation ischaemic stroke: study rationale and designXuehong Chu, Chuanjie Wu, Yifeng Liu et al.|Stroke and Vascular Neurology|2024Cited by 16